Study Finds ADHD Prevalence Stable Amid Ongoing Medication Shortages

A recent study has determined that the prevalence of Attention Deficit Hyperactivity Disorder (ADHD) has not increased, despite ongoing shortages of medications used to treat the condition. The findings come amid heightened demand for ADHD drugs, which have faced supply chain challenges in recent months.

Researchers conducted an analysis to assess whether ADHD diagnoses have been rising, as some had speculated due to increased awareness and medication use. The study concluded that there is no evidence of a significant uptick in cases. However, the demand for ADHD medications remains high, contributing to persistent shortages reported by pharmacies and healthcare providers. These supply issues have raised concerns among patients and medical professionals about access to treatment options for those managing the disorder.

Newsflash | Powered by GeneOnline AI

Source: GO-AI-ne1

Date: June 6, 2025

Related posts:

Pharmaceutical Companies Can Cut Costs by Outsourcing Manufacturing to CDMOs, Freeing Resources for Drug Development: DrugPatentWatch DrugPatentWatch Article: Market Share and Competition Impact Generic Drug Pricing Strategies GLP-1 Receptor Agonists and FGF21 Analogs Investigated for MASH-Related Cirrhosis Treatment Scientific Advancements and Cultural Shifts Drive Innovation in Pharmaceutical Industry

Author

Mark Chiang